Covington Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.97M | Sell |
79,736
-3,384
| -4% | -$169K | 0.17% | 133 |
|
|
2022
Q2 | $4.63M | Sell |
83,120
-500
| -0.6% | -$27.9K | 0.19% | 130 |
|
|
2022
Q1 | $4.64M | Sell |
83,620
-104
| -0.1% | -$5.78K | 0.17% | 137 |
|
|
2021
Q4 | $4.69M | Sell |
83,724
-2,098
| -2% | -$117K | 0.16% | 137 |
|
|
2021
Q3 | $4.12M | Buy |
85,822
+6
| +0% | +$288 | 0.16% | 143 |
|
|
2021
Q2 | $3.59M | Sell |
85,816
-830
| -1% | -$34.8K | 0.14% | 147 |
|
|
2021
Q1 | $2.92M | Hold |
86,646
| – | – | 0.13% | 150 |
|
|
2020
Q4 | $3.03M | Sell |
86,646
-2,700
| -3% | -$94.3K | 0.14% | 141 |
|
|
2020
Q3 | $3.1M | Sell |
89,346
-900
| -1% | -$31.2K | 0.15% | 138 |
|
|
2020
Q2 | $2.96M | Sell |
90,246
-92,170
| -51% | -$3.02M | 0.16% | 134 |
|
|
2020
Q1 | $5.49M | Buy |
182,416
+7,880
| +5% | +$237K | 0.36% | 79 |
|
|
2019
Q4 | $5.05M | Sell |
174,536
-2,290
| -1% | -$66.3K | 0.27% | 107 |
|
|
2019
Q3 | $4.57M | Sell |
176,826
-10,250
| -5% | -$265K | 0.26% | 106 |
|
|
2019
Q2 | $4.77M | Sell |
187,076
-47,230
| -20% | -$1.21M | 0.28% | 96 |
|
|
2019
Q1 | $6.13M | Sell |
234,306
-12,400
| -5% | -$324K | 0.38% | 82 |
|
|
2018
Q4 | $5.68M | Sell |
246,706
-2,604
| -1% | -$60K | 0.4% | 77 |
|
|
2018
Q3 | $5.88M | Buy |
249,310
+39,760
| +19% | +$937K | 0.36% | 81 |
|
|
2018
Q2 | $4.83M | Buy |
209,550
+25,610
| +14% | +$591K | 0.31% | 91 |
|
|
2018
Q1 | $4.53M | Buy |
183,940
+8,630
| +5% | +$213K | 0.3% | 93 |
|
|
2017
Q4 | $4.7M | Buy |
175,310
+4,704
| +3% | +$126K | 0.29% | 93 |
|
|
2017
Q3 | $4.11M | Buy |
+170,606
| New | +$4.11M | 0.27% | 98 |
|